Blood clot (deep vein thrombosis) - Causes, Treatment & When to See a Doctor

```html

What is Blood clot (deep vein thrombosis)?

Deep vein thrombosis (DVT) is a condition in which a blood clot (thrombus) forms in the deep veins of the body, most commonly in the lower extremities (the thighs or calves). The clot can partially or completely block blood flow, leading to swelling, pain, and skin changes. If a piece of the clot breaks free, it can travel through the bloodstream to the lungs and cause a life‑threatening pulmonary embolism (PE). DVT is a serious medical problem that requires prompt evaluation, but early detection and treatment dramatically reduce the risk of complications.

According to the CDC, about 1 in 1,000 adults in the United States experiences a DVT each year, and the risk rises sharply with age, immobility, and certain medical conditions.

Common Causes

Most DVT cases develop when three factors—stasis of blood flow, injury to the vessel wall, and a hypercoagulable (clot‑prone) state—come together (Virchow’s triad). The following conditions or situations increase the likelihood of a clot forming in a deep vein.

• Prolonged immobility – lengthy travel (airplane, car, train) or bed rest after surgery.
• Recent surgery or trauma – especially orthopedic procedures on the hip, knee, or pelvis, and major fractures.
• Cancer and cancer treatments – tumors release pro‑coagulant substances; chemotherapy and radiation can damage vessels.
• Inherited or acquired clotting disorders – Factor V Leiden, prothrombin gene mutation, antiphospholipid syndrome, or elevated homocysteine.
• Hormonal influences – estrogen‑containing oral contraceptives, hormone replacement therapy, and pregnancy.
• Obesity – excess body weight increases pressure in the veins of the pelvis and legs, slowing blood flow.
• Chronic heart failure or respiratory disease – reduced cardiac output and low‑oxygen states promote stasis.
• Inflammatory diseases – inflammatory bowel disease, rheumatoid arthritis, and lupus can make blood more prone to clotting.
• Central venous catheters or pacemaker leads – foreign bodies can irritate the vessel wall and trigger clot formation.
• Smoking – damages the lining of blood vessels and increases clotting factors.

Associated Symptoms

Symptoms of DVT can be subtle, especially in the early stages. When they do appear, they usually affect the affected leg (or, less commonly, an arm) and may include:

• Swelling – often in the calf or entire leg; may feel tight or “full.”
• Pain or tenderness – described as a cramp, achy, or throbbing sensation that worsens with standing or walking.
• Warmth – the skin over the clot may feel warmer than the opposite leg.
• Red or discolored skin – a bluish hue or a reddish streak along the vein.
• Visible surface veins – superficial veins may become more prominent as deeper veins become obstructed.
• Leg heaviness or fatigue – a sensation that the leg is “dragged down.”
• Shortness of breath, chest pain, or rapid heartbeat – these suggest that a clot may have traveled to the lungs (pulmonary embolism) and demand emergency care.

When to See a Doctor

Because DVT can lead to a pulmonary embolism, any new, unexplained leg swelling or pain should be evaluated promptly. Seek medical attention if you notice:

• Swelling in one leg that does not improve after 24 hours of rest.
• Severe, sudden calf pain that feels like a “charley horse” and does not go away.
• Redness, warmth, or a visible vein that’s become larger.
• Shortness of breath, chest discomfort, or coughing up blood‑colored sputum.
• Recent major surgery, trauma, or a long flight (≥4 hours) combined with leg pain.
• History of clotting disorder or previous DVT/PE.

Even if symptoms are mild, contact your primary‑care provider or go to an urgent‑care clinic. Early treatment dramatically lowers the risk of complications.

Diagnosis

Physicians use a combination of clinical assessment, risk‑scoring tools, and imaging studies to confirm DVT.

Clinical evaluation

• History & physical exam – doctors assess risk factors and look for leg asymmetry, tenderness over the calf, and swelling.
• Wells score for DVT – a point‑system that estimates pre‑test probability. A score ≥2 suggests “moderate” or “high” probability and guides further testing.

Laboratory test

• D‑dimer – a blood fragment released when a clot dissolves. A normal D‑dimer makes DVT unlikely in low‑risk patients, but an elevated level is non‑specific.

Imaging studies

• Compression ultrasonography (duplex ultrasound) – the first‑line test. It visualizes vein compression and blood flow; a non‑compressible vein indicates a clot.
• Venography – contrast dye injected into a vein followed by X‑ray; rarely used today because ultrasound is non‑invasive.
• CT or MR venography – reserved for pelvic or upper‑extremity DVT when ultrasound is limited.

Additional tests for complications

• If pulmonary embolism is suspected, a CT pulmonary angiogram or a ventilation‑perfusion (V/Q) scan is performed.

Treatment Options

The primary goals of DVT treatment are to prevent clot extension, reduce the risk of pulmonary embolism, and lessen the chance of long‑term complications such as post‑thrombotic syndrome.

Anticoagulant medications

• Direct oral anticoagulants (DOACs) – apixaban, rivaroxaban, edoxaban, and dabigatran are now first‑line because they have predictable effects and do not require routine blood monitoring (Mayo Clinic).
• Warfarin – a vitamin K antagonist that requires INR monitoring; used when DOACs are contraindicated (e.g., severe kidney disease).
• Heparin – unfractionated or low‑molecular‑weight (LMWH) heparin given subcutaneously as a bridge to oral therapy.

Thrombolytic therapy

In selected cases with extensive clot burden, severe symptoms, or limb‑threatening ischemia, clot‑busting drugs (e.g., alteplase) may be administered via catheter. This approach carries a higher bleeding risk and is reserved for specialized centers.

Mechanical interventions

• Catheter‑directed thrombectomy – physically removes clot; used when thrombolysis is contraindicated.
• Inferior vena cava (IVC) filter – a tiny metal device placed in the IVC to catch clots traveling toward the lungs. Considered only if anticoagulation is impossible.

Supportive measures

• Compression stockings – graduated (30‑40 mmHg) to reduce swelling and lower the risk of post‑thrombotic syndrome (Cleveland Clinic).
• Elevation and ambulation – raising the leg above heart level when possible and gentle walking improve venous return.
• Hydration – adequate fluid intake helps maintain blood volume and flow.

Duration of therapy

Typical treatment length depends on the underlying cause:

• Provoked DVT (e.g., surgery, immobilization) – 3–6 months of anticoagulation.
• Unprovoked DVT or persistent risk factors – at least 6 months; many clinicians recommend indefinite anticoagulation if bleeding risk is low.
• Patients with recurrent clotting or strong hereditary thrombophilia may need lifelong therapy.

Prevention Tips

Many DVTs are preventable through lifestyle adjustments, medical strategies, and awareness during high‑risk periods.

• Stay mobile – Take a walk or calf‑pump exercises every 1–2 hours during long flights, road trips, or after surgery.
• Wear compression hosiery – especially for travel >4 hours or if you have varicose veins.
• Maintain a healthy weight – Aim for a BMI < 25 kg/m² through balanced diet and regular activity.
• Quit smoking – Smoking cessation improves vessel health and reduces clotting risk.
• Manage chronic conditions – Keep diabetes, hypertension, and heart failure well‑controlled.
• Consider prophylactic anticoagulation – For high‑risk surgery or prolonged immobilization, doctors may prescribe low‑dose LMWH or DOACs (per CDC guidelines).
• Stay hydrated – Dehydration can thicken blood; drink water regularly, especially when traveling.
• Avoid tight clothing – Restrictive garments around the waist or legs can impede venous flow.

Emergency Warning Signs

---

© 2026 HealthGuide. Content reviewed by board‑certified physicians. Sources: Mayo Clinic, CDC, NIH, WHO, Cleveland Clinic, New England Journal of Medicine, Journal of Thrombosis and Haemostasis.

```